ReviewNature methods2026
Recent developments of fluorescent proteins and biosensors driven by cross-disciplinary insights.
Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Since the discovery and application of green fluorescent protein for use as an optical tag, fluorescent proteins (FPs) have changed the way we observe biological signals and processes. FP and fluorescent biosensor design has continued to advance, facilitated by new technologies and developments in chemistry, physics, engineering and screening technologies. We summarize some of the recent developments in FP engineering, focusing on insights that have led to improved photostability or longer wavelengths, among other improvements, highlighting mScarlet as a case study. We also discuss the engineering of new fluorescent biosensors, focusing on the ways in which screening, quantitative imaging, spatial resolution and multiplexing have been improved in recent years. Finally, we conclude with a perspective on what the future holds for the next generation of FPs and biosensors.
Identifiers
42888239What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.